Mehta Piyush 4
4 · Genpact LTD · Filed Sep 15, 2025
Insider Transaction Report
Form 4
Mehta Piyush
Senior Vice President and CHRO
Transactions
- Exercise/Conversion
Common Shares
2025-09-12$31.50/sh+50,000$1,575,000→ 211,782 total - Sale
Common Shares
2025-09-12$42.58/sh−50,000$2,129,000→ 161,782 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-09-12−50,000→ 0 totalExercise: $31.50Exp: 2028-04-01→ Common Shares (50,000 underlying) - Sale
Common Shares
2025-09-12$42.58/sh−26,902$1,145,487→ 134,880 total
Footnotes (4)
- [F1]Includes 284 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 10,222 shares under the ESPP.
- [F2]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.42 to $42.73. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.42 to $42.70. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The option vested 50% on April 2, 2021 and the remainder on April 2, 2023.